Baculovirus-insect cell expression, purification, and immunological studies of the full-length Japanese encephalitis virus envelope protein

Enzyme and Microbial Technology

Volumn 33, Issue 4, 2003, Pages 438-444

  Wu, Suh Chin ^a   Lin, Ying Ju ^a   Yu, Ching Hung ^a  

^a NATIONAL TSING HUA UNIVERSITY   (Taiwan)

Author keywords

Baculovirus; E protein; Japanese encephalitis virus; Neutralizing antibodies; Protective immunity

Indexed keywords

AFFINITY CHROMATOGRAPHY; ANIMAL CELL CULTURE; EMULSIONS; IMMUNOLOGY; PROTEINS; VIRUSES;

CYTOPLASMS;

ANTIGEN-ANTIBODY REACTIONS;

FREUND ADJUVANT; JAPANESE ENCEPHALITIS VACCINE; NEUTRALIZING ANTIBODY; RECOMBINANT VACCINE; SIGNAL PEPTIDE; VIRUS ENVELOPE PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ANTIGENIC MODULATION; ARTICLE; BACULOVIRUS EXPRESSION SYSTEM; CONTROLLED STUDY; DRUG EFFECT; EMULSION; EPIDEMIC ENCEPHALITIS; EXPRESSION VECTOR; IMMOBILIZED METAL AFFINITY CHROMATOGRAPHY; IMMUNOPHARMACOLOGY; IMMUNOSURVEILLANCE; INSECT CELL; JAPANESE ENCEPHALITIS VIRUS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; PROTEIN PURIFICATION;

INSECTA; JAPANESE ENCEPHALITIS VIRUS; UNIDENTIFIED BACULOVIRUS;

EID: 0041930713     PISSN: 01410229     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0141-0229(03)00142-X     Document Type: Article

References (30)

1. Burke DS, Monath TP. Falviviruses. In: Fields BN, Knipe DM, Howley PM, editors. Fields virology, 4th ed. Philadelphia, PA: Lippincott-Raven; 2001. p. 1043-125.
2. Hoke C.H., Nisalak A., Sangawhipa N., Jatanasen S., Laorakapongse T., Innis B.L.et al. Protection against Japanese encephalitis by inactivated vaccines. N. Eng. J. Med. 319:1988;608-614.
3. Kurane I., Takasaki K. Immunogenicity and protective efficacy of the current inactivated Japanese encephalitis vaccine against different Japanese encephalitis virus strains. Vaccine. 18:2000;33-35.
4. Russell R.C., Dwyer D.E. Arboviruses associated with human disease in Australia. Microbes Infect. 2:2000;1693-1704.
5. Tsai T.F. New initiatives for the control of Japanese encephalitis by vaccination: minutes of a WHO/CVI meeting, Bangkok, Thailand, 13-15 October 1998. Vaccine. 18:2000;1-25.
6. Chambers T.J., Tsai T.F., Previkov Y., Monath T.P. Vaccine development against dengue and Japanese encephalitis: report of a World Health Organization meeting. Vaccine. 15:1997;1494-1502.
7. McMinn P.C. The molecular basis of virulence of the encephalitogenic flaviviruses. J. Gen. Virol. 78:1997;2711-2722.
8. Rey F.A., Heinz F.X., Mandl C.W., Kunz C., Harrison S.C. The envelope glycoprotein from tick-borne encephalitis virus at 2 Å resolution. Nature. 375:1995;291-298.
9. Kuhn R.J., Zhang W., Rossmann M.G., Pletnev S.V., Corver J., Lenches E. et al. Structure of dengue virus: implications for flavivirus organization maturation and fusion. Cell. 108:2002;717-725.
10. Mason P.W., Zugel M.U., Semproni A.R., Fournier M.J., Mason T.L. The antigenic structure of dengue type 1 virus envelope and NS1 proteins expressed in Escherichia coli. J. Gen. Virol. 71:1990;2107-2114.
11. Surgue R.J., Fu J., Howe J., Chan Y.-C. Expression of the dengue virus structural proteins in Pichia pastoris leads to the generation of virus-like particles. J. Gen. Virol. 78:1997;1861-1866.
12. Matsuura Y., Miyamoto M., Sato T., Morita C., Yasui K. Characterization of Japanese encephalitis virus envelope protein expressed by recombinant baculoviruses. Virology. 173:1989;674-682.
13. McCown J., Cochran M., Putnak R., Feighny R., Burrous J., Henchal E.et al. Protection of mice against lethal Japanese encephalitis with a recombinant baculovirus vaccine. Am. J. Trop. Med. Hyg. 42:1990;491-499.
14. Smucny J.J., Kelly E.P., Macarthy P.O., King A.D. Murine immunoglobulin G subclass responses following immunization with live dengue virus or a recombinant dengue envelope protein. Am. J. Trop. Med. Hyg. 53:1995;432-437.
15. Bielefeldt-Ohmann H., Beasley D.W.C., Fitzpatrick D.R., Aaskov J.G. Analysis of a recombinant dengue-2 virus-dengue-3 virus hybrid envelope protein expressed in a secretory baculovirus system. J. Gen. Virol. 78:1997;2723-2733.
16. Staropoli I., Frenkiel M.-P., Megret F., Deubel V. Affinity-purified dengue-2 virus envelope glycoprotein induces neutralizing antibodies and protective immunity in mice. Vaccine. 15:1997;1946-1954.
17. Velzing J., Groen J., Drouet M.T., van Amerongen G., Copra C., Osterhaus A.D.M.E.et al. Induction of protective immunity against dengue virus type 2: comparison of candidate live attenuated and recombinant vaccines. Vaccine. 17:1999;1312-1320.
18. Marx F., Gritsun T.S., Grubeck-Loebenstein B., Gold E.A. Diagnostic immunoassays for tick-borne encephalitis virus based on recombinant baculovirus protein expression. J. Virol. Methods. 91:2001;75-84.
19. Allison S.L., Stadler K., Mandl C.W., Kunz C., Heinz F.X. Synthesis and secretion of recombinant tick-borne encephalitis virus protein E in soluble and particulate form. J. Virol. 69:1995;5816-5820.
20. Konish E., Fujji E., Mason P.W. Generation and characterization of a mammalian cell line continuously expressing Japanese encephalitis virus subviral particles. J. Virol. 75:2001;2204-2212.
21. Hunt A.R., Cropp C.B., Chang G.J.J. A recombinant particulate antigen of Japanese encephalitis virus produced in stably-transformed cells is an effective noninfectious antigen and subunit immunogen. J. Virol. Methods. 97:2001;133-149.
22. Konishi E., Fujii E. Dengue type 2 virus subviral extracellular particles produced by a stably transfected mammalian cell line and their evaluation for a subunit vaccine. Vaccine. 20:2002;1058-1067.
23. Jarvis DL. Baculovirus expression vectors. In: Miller LK, editor. The baculoviruses. New York: Plenum Press; 1997. p. 389-431.
24. Wu S.-C., Lian W.-C., Hsu L.-C., Liau M.-Y. Japanese encephalitis virus antigenic variants with characteristic differences in neutralization resistance and mouse virulence. Virus Res. 51:1997;173-181.
25. Wu S.-C., Lian W.-C., Hsu L.-C., Wu Y.-C., Liau M.-Y. Antigenic characterization of nine wild-type Taiwanese isolates of Japanese encephalitis virus as compared with two vaccine strains. Virus Res. 55:1998;83-91.
26. Wu S.-C., Lee S.-C. Complete nucleotide sequence and cell-line multiplication pattern of the attenuated variant CH2195LA of Japanese encephalitis virus. Virus Res. 73:2001;91-102.
27. Mandl C.W., Heinz F.X., Kunz C. Sequence of the structural proteins of tick-borne encephalitis virus (Western subtype) and comparative analysis with other flaviviruses. Virology. 166:1989;197-205.
28. Depres P.A., Ruiz-Linares A., Cahour A., Girard M., Sychowski C., Bouloy M. Processing, secretion and immunoreactivity of carboxy terminally truncated dengue-2 envelope proteins expressed in insect cells by recombinant baculoviruses. Virology. 180:1991;442-447.
29. Markoff L., Chang A., Falgout B. Processing of flavivirus structural glycoproteins: stable membrane insertion of premembrane requires the envelope signal peptide. Virology. 204:1994;526-540.
30. Kelly E.P., Greene J.J., King A.D., Innis B.L. Purified dengue 2 envelope glycoprotein aggregates produced by baculovirus are immunogenic in mice. Vaccine. 18:2000;2549-2559.